Clinical trial
PHARES Study: Management of Resistant Hypertension
NCT00224549 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00224549 |
|---|---|
| Title | PHARES Study: Management of Resistant Hypertension |
| Official title | Management of Resistant Hypertension -Pharmacokinetic Assessment of Different Antihypertensive Regimen -Comparison of Two Treatment Strategies: Increase Sodium Depletion or Combined Blockage of Renin-angiotensin System (RAS) |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | irbesartan, amlodipine and hydrochlorothiazide |
| Enrollment | 180 |
| Start date | Apr 1, 2005 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Sep 23, 2005 |
| Last update posted | Feb 28, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: